Filter
Sort
By using single-cell analysis to measure metabolic activities in rare disseminated tumor cells taken from non-small cell lung cancer (NSCLC) patients, ISB researchers and their collaborators can accurately predict how patients will respond to various cancer therapies, and how treatments will impact a patient’s physiological performance and survival.
ISB’s Dr. Sui Huang uses the theory of complex systems and applies it to cancer research. In this video Q&A, he discusses the cancer paradox and highlights the importance of understanding the mechanism of why cancer treatments can backfire in order to open a new avenue for therapy and treatments.
Pregnancy is a biological necessity for survival. Traditionally, however, our knowledge about pregnancy and pregnant women have lagged. Dr. Alison Paquette, a research scientist in ISB’s Hood-Price Lab, hosted a video question-and-answer session where she discussed pregnancy, the placenta, preterm birth, and much more.
About 75 people attended “Reimagine,” ISB’s annual fundraiser, and contributed nearly $35,000 to accelerate groundbreaking research. The event was held at The Ruins, and featured presentations by legendary biologist and ISB Co-founder Dr. Lee Hood and renowned scientist and ISB President Dr. Jim Heath.
The Andy Hill Cancer Research Endowment (CARE) is a public-private partnership that supports cancer research in Washington state. CARE announced ISB Assistant Professor Dr. Wei Wei as a CARE Fund Distinguished Researcher and awarded him $500,000.
ISB’s 18th Annual International Symposium, called Future of Health, featured accomplished scientists and leaders from industry and academia who discussed how concepts and innovations are translated from the lab into real-world clinical applications and therapies. Presentation videos from the two-day event are available here.